285 related articles for article (PubMed ID: 29604361)
1. The vitamin D receptor regulates miR-140-5p and targets the MAPK pathway in bone development.
Luo W; Liu L; Yang L; Dong Y; Liu T; Wei X; Liu D; Gu H; Kong J; Yuan Z; Zhao Q
Metabolism; 2018 Aug; 85():139-150. PubMed ID: 29604361
[TBL] [Abstract][Full Text] [Related]
2. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
3. Mineralization of three-dimensional osteoblast cultures is enhanced by the interaction of 1α,25-dihydroxyvitamin D3 and BMP2 via two specific vitamin D receptors.
Chen J; Dosier CR; Park JH; De S; Guldberg RE; Boyan BD; Schwartz Z
J Tissue Eng Regen Med; 2016 Jan; 10(1):40-51. PubMed ID: 23784946
[TBL] [Abstract][Full Text] [Related]
4. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells.
Chen S; Bu D; Ma Y; Zhu J; Chen G; Sun L; Zuo S; Li T; Pan Y; Wang X; Liu Y; Wang P
Neoplasia; 2017 Mar; 19(3):226-236. PubMed ID: 28189050
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D stimulates miR-26b-5p to inhibit placental COX-2 expression in preeclampsia.
Cao Y; Jia X; Huang Y; Wang J; Lu C; Yuan X; Xu J; Zhu H
Sci Rep; 2021 May; 11(1):11168. PubMed ID: 34045549
[TBL] [Abstract][Full Text] [Related]
6. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells.
Alimirah F; Peng X; Gupta A; Yuan L; Welsh J; Cleary M; Mehta RG
Exp Cell Res; 2016 Nov; 349(1):15-22. PubMed ID: 27693451
[TBL] [Abstract][Full Text] [Related]
8. Astemizole promotes the anti-tumor effect of vitamin D through inhibiting miR-125a-5p-meidated regulation of VDR in HCC.
Xu J; Wang Y; Zhang Y; Dang S; He S
Biomed Pharmacother; 2018 Nov; 107():1682-1691. PubMed ID: 30257386
[TBL] [Abstract][Full Text] [Related]
9. Mannose receptor C type 2 mediates 1,25(OH)
Dong Y; Yang L; Luo W; Zhu T; Yan W; Kong J; Yuan Z; Zhao Q
Mol Cell Endocrinol; 2019 Mar; 483():74-86. PubMed ID: 30641101
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
11. [Identification of microRNAs targeting vitamin D receptor and their effect on parathyroid hormone secretion in secondary hyperparathyroidism].
Jiang H; Li P; Liu L; Huang S; Li J; Wu W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):509-517. PubMed ID: 35527486
[TBL] [Abstract][Full Text] [Related]
12. Decreased microRNA-182-5p helps alendronate promote osteoblast proliferation and differentiation in osteoporosis via the Rap1/MAPK pathway.
Pan BL; Tong ZW; Li SD; Wu L; Liao JL; Yang YX; Li HH; Dai YJ; Li JE; Pan L
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413613
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control.
Yamamoto Y; Yoshizawa T; Fukuda T; Shirode-Fukuda Y; Yu T; Sekine K; Sato T; Kawano H; Aihara K; Nakamichi Y; Watanabe T; Shindo M; Inoue K; Inoue E; Tsuji N; Hoshino M; Karsenty G; Metzger D; Chambon P; Kato S; Imai Y
Endocrinology; 2013 Mar; 154(3):1008-20. PubMed ID: 23389957
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D Receptor Gene Expression in Adipose Tissue of Obese Individuals is Regulated by miRNA and Correlates with the Pro-Inflammatory Cytokine Level.
Jonas MI; Kuryłowicz A; Bartoszewicz Z; Lisik W; Jonas M; Kozniewski K; Puzianowska-Kuznicka M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652924
[No Abstract] [Full Text] [Related]
15. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
16. Evidence for coordinated regulation of osteoblast function by 1,25-dihydroxyvitamin D3 and parathyroid hormone.
van Leeuwen JP; Birkenhäger JC; van den Bemd GC; Pols HA
Biochim Biophys Acta; 1996 Jun; 1312(1):54-62. PubMed ID: 8679716
[TBL] [Abstract][Full Text] [Related]
17. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
19. miR-219a-5p Regulates Rorβ During Osteoblast Differentiation and in Age-related Bone Loss.
Aquino-Martinez R; Farr JN; Weivoda MM; Negley BA; Onken JL; Thicke BS; Fulcer MM; Fraser DG; van Wijnen AJ; Khosla S; Monroe DG
J Bone Miner Res; 2019 Jan; 34(1):135-144. PubMed ID: 30321475
[TBL] [Abstract][Full Text] [Related]
20. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCδ/ERK Signaling Pathway.
He XJ; Ding Y; Xiang W; Dang XQ
Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
